Longitudinal evaluation of SNOT-22 can distinguish patients with chronic rhinosinusitis with nasal polyps who respond quickly to monoclonal antibodies.
The post SNOT-22 Tracking Optimizes Therapy Selection in CRSwNP first appeared on Physician’s Weekly.
